Erratum
Erratum to expanded criteria for active surveillance in prostate cancer: a review of the current data
Expanded criteria for active surveillance in prostate cancer: a review of the current data
The article entitled “Expanded criteria for active surveillance in prostate cancer: a review of the current data” (1) published in Vol 7, No 2 of Translational Andrology and Urology included an error in the second sentence of Abstract. In that sentence, “mortality (PCSM)” should be changed to “survival”.
Therefore, the correct sentence should be “Appropriately selected AS patients have a 10-year prostate cancer-specific survival approaching 99%.”
We regret the error and any inconvenience it might have caused.
References
- Jones C, Fam MM, Davies BJ. Expanded criteria for active surveillance in prostate cancer: a review of the current data. Transl Androl Urol 2018;7:221-7. [Crossref] [PubMed]
Cite this article as: Jones C, Fam MM, Davies BJ. Erratum to expanded criteria for active surveillance in prostate cancer: a review of the current data. Transl Androl Urol 2018;7(4):764. doi: 10.21037/tau.2018.08.05
